| Financial Insitution | Analyst | Recommandation | Target price |
| Portzamparc | Mohamed Kaabouni | Buy1 | €5.50 |
| TP ICAP Midcap | Claire Deray | Buy2 | €6.20 |
Click here to access TP ICAP Midcap's initiation study in PDF / web format (in French only)
1 The investment recommendation was made on April 22, 2021 - 9:22 am (GMT+1) and was first released on April 22, 2021 - 9:28 am (GMT+1). This information does not constitute an offer to sell or subscribe, or the solicitation of an order to buy or subscribe for securities in France, Europe, the US or any other country.
2 The investment recommendation was made on April 6, 2023 - 7:51 am (GMT+1) and was first released on April 6, 2023 - 8:23 am (GMT+1). This information does not constitute an offer to sell or subscribe, or the solicitation of an order to buy or subscribe for securities in France, Europe, the US or any other country. The provision of a service for the production and dissemination of financial analysis has been agreed between Pherecydes Pharma and TP ICAP Midcap.